G. Zoller

发表

Identification and synthesis of novel inhibitors of acetyl-CoA carboxylase with in vitro and in vivo efficacy on fat oxidation.

Marco Müller, Katrin Schroeter, D. Schmoll, 2010, Journal of medicinal chemistry.

Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).

H. Matter, A. Herling, S. Keil, 2013, European journal of pharmacology.

Stimulation of Fat Oxidation, but no Sustained Reduction of Hepatic Lipids by Prolonged Pharmacological Inhibition of Acetyl CoA Carboxylase

D. Schmoll, A. Herling, S. Keil, 2011, Hormone and Metabolic Research.

Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand.

H. Matter, H. Schreuder, V. Laux, 2004, Bioorganic & medicinal chemistry letters.

Discovery of an orally active non-peptide fibrinogen receptor antagonist.

J. Knolle, E. Paulus, G. Zoller, 1996, Journal of medicinal chemistry.

Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold.

W. Guba, W. König, V. Wehner, 2001, Journal of medicinal chemistry.

Amino acids; 13

F. Effenberger, G. Zoller, 1988 .

From a peptide lead to an orally active peptidomimetic fibrinogen receptor antagonist

W. Guba, W. König, V. Wehner, 1998, Letters in Peptide Science.

Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.

H. Matter, A. Herling, J. Sánchez-Arias, 2013, Bioorganic & medicinal chemistry letters.